Study of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C Reduction

NCT04797247 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

900

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Diseases
Hyper-LDL-cholesterolemia

Interventions

DRUG: lerodalcibep

Sponsor

LIB Therapeutics LLC

Collaborators

[object Object]